- Home
- ACET vs PED Comparison
ACET vs PED Comparison
Compare ACET & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- PED
- Stock Information
- Founded
- ACET 1947
- PED N/A
- Country
- ACET United States
- PED United States
- Employees
- ACET N/A
- PED N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- PED Oil & Gas Production
- Sector
- ACET Health Care
- PED Energy
- Exchange
- ACET Nasdaq
- PED Nasdaq
- Market Cap
- ACET 55.1M
- PED 48.8M
- IPO Year
- ACET N/A
- PED N/A
- Fundamental
- Price
- ACET $0.75
- PED $0.65
- Analyst Decision
- ACET Buy
- PED Strong Buy
- Analyst Count
- ACET 6
- PED 2
- Target Price
- ACET $6.00
- PED $1.63
- AVG Volume (30 Days)
- ACET 768.4K
- PED 100.6K
- Earning Date
- ACET 05-06-2025
- PED 05-15-2025
- Dividend Yield
- ACET N/A
- PED N/A
- EPS Growth
- ACET N/A
- PED 2248.88
- EPS
- ACET N/A
- PED 0.19
- Revenue
- ACET N/A
- PED $40,173,000.00
- Revenue This Year
- ACET N/A
- PED N/A
- Revenue Next Year
- ACET N/A
- PED $5.99
- P/E Ratio
- ACET N/A
- PED $3.38
- Revenue Growth
- ACET N/A
- PED 30.70
- 52 Week Low
- ACET $0.45
- PED $0.47
- 52 Week High
- ACET $1.70
- PED $1.10
- Technical
- Relative Strength Index (RSI)
- ACET 56.33
- PED 58.18
- Support Level
- ACET $0.64
- PED $0.59
- Resistance Level
- ACET $0.72
- PED $0.66
- Average True Range (ATR)
- ACET 0.06
- PED 0.04
- MACD
- ACET 0.01
- PED 0.00
- Stochastic Oscillator
- ACET 74.37
- PED 71.87
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.